Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autotaxin and chronic inflammatory diseases
Christiana Magkrioti, Apostolos Galaris, Paraskevi Kanellopoulou, et al.
Journal of Autoimmunity (2019) Vol. 104, pp. 102327-102327
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Structure and function of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) family: Tidying up diversity
Razvan Borza, Fernando Salgado-Polo, Wouter H. Moolenaar, et al.
Journal of Biological Chemistry (2021) Vol. 298, Iss. 2, pp. 101526-101526
Open Access | Times Cited: 85
Pharmacological targeting of ECM homeostasis, fibroblast activation, and invasion for the treatment of pulmonary fibrosis
Ioannis Tomos, Paraskevi Kanellopoulou, Dimitris Nastos, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access | Times Cited: 1
Obesity and Cancer Metastasis: Molecular and Translational Perspectives
Stephanie Annett, Gillian Moore, Tracy Robson
Cancers (2020) Vol. 12, Iss. 12, pp. 3798-3798
Open Access | Times Cited: 65
The current landscape of antifibrotic therapy across different organs: A systematic approach
Isabel Fuster‐Martínez, Sara Calatayud
Pharmacological Research (2024) Vol. 205, pp. 107245-107245
Open Access | Times Cited: 7
Using comprehensive lipid profiling to study effects of PFHxS during different stages of early zebrafish development
Mengmeng Xu, Jessica Legradi, P.E.G. Leonards
The Science of The Total Environment (2021) Vol. 808, pp. 151739-151739
Open Access | Times Cited: 40
Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling
Nikhil Rangholia, Thomas Leisner, Stephen P. Holly
Metabolites (2021) Vol. 11, Iss. 1, pp. 41-41
Open Access | Times Cited: 39
Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation
Francesca M. Trovato, Rabiya Zia, Salvatore Napoli, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 907-925
Open Access | Times Cited: 38
Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
Konstantinos Ntatsoulis, Τheodoros Karampitsakos, Eliza Tsitoura, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis
Olivier Burgy, Sabrina Loriod, Guillaume Beltramo, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1209-1209
Open Access | Times Cited: 27
Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
Jing Zhang, Yang Xiao, Jingyi Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
Asahiro Morishita, Kyoko Oura, Kei Takuma, et al.
Hepatology International (2022) Vol. 17, Iss. 3, pp. 606-614
Open Access | Times Cited: 24
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao Chen, Yang Zhou, Haiping Hao, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 8, pp. 724-745
Closed Access | Times Cited: 5
Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
David N. Brindley, Xiaoyun Tang, Guanmin Meng, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5938-5938
Open Access | Times Cited: 39
ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker
Μαρία Παναγοπούλου, Andrianna Drosouni, Dionysiοs Fanidis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 19
Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer
Mélanie A. Dacheux, Derek D. Norman, Gábor Tigyi, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108414-108414
Open Access | Times Cited: 13
Synthesis of Autotaxin-Inhibiting Lipid Nanoparticles to Regulate Autophagy and Inflammatory Responses in Activated Macrophages
Sohee Jeon, Jun Seong Kwon, H KO, et al.
Tissue Engineering and Regenerative Medicine (2025)
Closed Access
Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae
Matthew G.K. Benesch, Xiaoyun Tang, David N. Brindley
Cancers (2020) Vol. 12, Iss. 2, pp. 374-374
Open Access | Times Cited: 32
Signalling by lysophosphatidate and its health implications
Denise G. Hemmings, David N. Brindley
Essays in Biochemistry (2020) Vol. 64, Iss. 3, pp. 547-563
Closed Access | Times Cited: 31
Bioactive lipids in inflammatory bowel diseases – From pathophysiological alterations to therapeutic opportunities
Mireille Alhouayek, Hafsa Ameraoui, Giulio G. Muccioli
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1866, Iss. 2, pp. 158854-158854
Closed Access | Times Cited: 30
Transcriptional activation of ENPP2 by FoxO4 protects cardiomyocytes from doxorubicin‑induced toxicity
Ling He, Yuting Yang, Juan Chen, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 3
Open Access | Times Cited: 26
Design and Development of Autotaxin Inhibitors
Yi Jia, Yan Li, Xudong Xu, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1203-1203
Open Access | Times Cited: 25
Autotaxin regulates the expression and the activity of P-glycoprotein in lipopolysaccharide -activated microglial cells
Mohammad Fayyad‐Kazan, Zeina Soayfane, Wissam H. Faour, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Serum levels of autotaxin reveal its role as a novel biomarker of migraine
Alberto Ouro, Mónica Castro‐Mosquera, Mariña Rodríguez‐Arrizabalaga, et al.
Headache The Journal of Head and Face Pain (2025)
Open Access
Generation of New Knock-Out Mouse Strains of Lysophosphatidic Acid Receptor 1
Georgia Antonopoulou, Christiana Magkrioti, Ismini Chatzidaki, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2811-2811
Open Access
Amplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors
Elli-Anna Stylianaki, Christiana Magkrioti, Eleanna Kaffe, et al.
STAR Protocols (2025) Vol. 6, Iss. 2, pp. 103721-103721
Closed Access
Page 1 - Next Page

Scroll to top